iShares Global Healthcare ETF IXJ
At closeNov 3, 2026, 4:00 PM EST
After hours · Nov 3, 4:00 PM ET
- YTD
- +14.95%
- 1 year
- +22.75%
- Market cap
- 4.65B
- EPS (ttm)
- 3.78
- P/E ratio
- 29.65
- YTD return
- +14.95%
- 1-year return
- +22.75%
- Volume
- 218.85K
- Avg volume
- 217.84K
- Open
- 112.19
- Previous close
- 112.57
- Day's range
- 111.78 – 113.04
- 52-week range
- 90.28 – 114.06
1m +0.34 (+0.30%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 0
- Total debt
- 0
- Return on equity
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 104.93
- 200-day average
- 99.02
Next earnings
Consensus EPS estimate 0.00.
About iShares Global Healthcare ETF
The fund seeks to track the investment results of the S&P Global 1200 Health Care (Sector) Capped IndexTM (the “underlying index”), which measures the performance of companies that S&P Dow Jones Indices LLC (the “index provider” or “SPDJI”), a subsidiary of S&P Global, Inc., deems to be a part of the healthcare sector of the economy and that SPDJI believes are important to global markets. The underlying index is a subset of the S&P Global 1200, which is designed to measure the performance of large-capitalization stocks from major global markets, as determined by SPDJI.
News
iShares Global Healthcare ETF $IXJ Shares Newly Acquired by Everett Harris & Co. CA
Which Healthcare ETF Is the Better Buy: iShares' Global IXJ or First Trust's Biotech FBT?
Why Healthcare ETFs Are Hovering Around One-Year Highs
B. Riley Wealth Advisors Inc. Buys 6,811 Shares of iShares Global Healthcare ETF $IXJ
IYH Beats IXJ on Returns While Global Fund Offers Higher Yield
IXJ: Healthcare Sector Dashboard For September
Does Fidelity or iShares Have the Better Healthcare ETF For Investors Seeking Broad Exposure?
State Street XLV vs. iShares IXJ: Here's How These Healthcare ETFs Stack Up for Investors
IXJ vs XPH: Global Healthcare ETF or Pharma Focus?
KOSPI loses 7,000 in 24 hours as oil and yields hammer Korean stocks
Your note
Sign in to keep a note on IXJ — it syncs with the Stock Master app.
